Skip to main content

Commonwealth Equity Services, Llc

Source: SEC Form 13F · as of Mar 2026

Commonwealth Equity Services, Llc holds 93 biotech & pharma companies tracked by BioSniper, totaling $127.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

93

Total value held

$127.9M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.258,398$36.0M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)256,515$14.2M
REGNREGENERON PHARMACEUTICALS, INC.16,385$12.7M
EXELEXELIXIS, INC.173,762$7.5M
SNYSanofi131,654$6.3M
TGTXTG THERAPEUTICS, INC.180,285$6.0M
AQSTAquestive Therapeutics, Inc.1,082,680$4.5M
TEVATeva Pharmaceutical Industries Limited146,008$4.4M
ALNYALNYLAM PHARMACEUTICALS, INC.10,577$3.5M
ARWRARROWHEAD PHARMACEUTICALS, INC.55,076$3.5M
MRNAModerna, Inc.48,540$2.5M
JAZZJazz Pharmaceuticals plc12,131$2.3M
INCYIncyte Corp.20,889$2.0M
VKTXViking Therapeutics, Inc.51,289$1.7M
NTLAIntellia Therapeutics, Inc.94,186$1.2M
XERSXeris Biopharma Holdings, Inc.203,116$1.2M
IBRXImmunityBio, Inc.143,257$1.1M
GALTGALECTIN THERAPEUTICS INC367,113$1.0M
RXRXRECURSION PHARMACEUTICALS, INC.320,991$985K
INSMINSMED Inc5,737$938K
CAPRCAPRICOR THERAPEUTICS, INC.26,752$813K
GMABGenmab A/S28,509$765K
ZYMEZymeworks Inc.26,031$652K
IONSIONIS PHARMACEUTICALS INC7,829$588K
ONCBeOne Medicines Ltd.1,759$522K
APGEApogee Therapeutics, Inc.5,915$498K
ALTAltimmune, Inc.160,374$494K
OPKOPKO HEALTH, INC.430,906$491K
ARGXARGENX SE650$475K
ROIVRoivant Sciences Ltd.16,894$468K
CADLCandel Therapeutics, Inc.95,395$467K
SUPNSUPERNUS PHARMACEUTICALS, INC.8,602$445K
ADPTAdaptive Biotechnologies Corp32,017$444K
IVAInventiva S.A.77,561$430K
VCELVericel Corp11,961$385K
BBIOBridgeBio Pharma, Inc.5,093$378K
ACADACADIA PHARMACEUTICALS INC15,042$335K
CYTKCYTOKINETICS INC4,857$320K
AXSMAxsome Therapeutics, Inc.1,659$280K
ANIPANI PHARMACEUTICALS INC3,495$269K
FDMT4D Molecular Therapeutics, Inc.28,274$263K
TVTXTravere Therapeutics, Inc.8,709$259K
KNSAKiniksa Pharmaceuticals International, plc5,036$242K
LGNDLigand Pharmaceuticals Incorporated1,185$237K
ARDXARDELYX, INC.35,581$213K
KALVKalVista Pharmaceuticals, Inc.10,474$211K
RDYDR REDDYS LABORATORIES LTD14,898$206K
DFTXDefinium Therapeutics Inc.10,251$194K
IOVAIOVANCE BIOTHERAPEUTICS, INC.53,626$188K
EDSAEdesa Biotech, Inc.35,003$183K
SABSSAB BIOTHERAPEUTICS, INC.46,455$178K
PGENPRECIGEN, INC.45,925$178K
SLSSELLAS Life Sciences Group, Inc.38,470$163K
LCTXLineage Cell Therapeutics, Inc.102,828$162K
OGNOrganon & Co.26,726$160K
IVVDInvivyd, Inc.121,600$158K
ZNTLZentalis Pharmaceuticals, Inc.61,412$144K
GRFSGrifols S.A.17,269$139K
ADMAADMA BIOLOGICS, INC.13,704$123K
ZVRAZEVRA THERAPEUTICS, INC.13,184$123K
IMMXImmix Biopharma, Inc.12,820$117K
PRTAPROTHENA CORP PUBLIC LTD CO11,930$116K
LRMRLarimar Therapeutics, Inc.24,782$112K
OTLKOutlook Therapeutics, Inc.470,000$97K
OCULOCULAR THERAPEUTIX, INC10,447$88K
SIGASIGA TECHNOLOGIES INC13,733$73K
ABSIAbsci Corporation20,702$62K
ALVOAlvotech17,276$59K
ESPREsperion Therapeutics, Inc.21,050$58K
PDSBPDS Biotechnology Corp90,797$55K
HRTXHERON THERAPEUTICS, INC. /DE/59,726$48K
NEUPNeuphoria Therapeutics Inc.11,222$46K
VYGRVoyager Therapeutics, Inc.11,304$44K
PLXProtalix BioTherapeutics, Inc.19,461$42K
SGMOQSANGAMO THERAPEUTICS, INC157,811$39K
MIRAMIRA PHARMACEUTICALS, INC.35,067$38K
IXHLIncannex Healthcare Inc.12,112$36K
FATEFATE THERAPEUTICS INC29,048$35K
AVXLANAVEX LIFE SCIENCES CORP.10,513$32K
ONCYONCOLYTICS BIOTECH INC35,114$30K
LGVNLongeveron Inc.25,155$26K
GERNGERON CORP15,530$23K
BCDABioCardia, Inc.18,283$22K
NRSNNeuroSense Therapeutics Ltd.22,775$17K
SBFMSUNSHINE BIOPHARMA INC.13,437$14K
SCNXScienture Holdings, Inc.44,798$13K
IMUXIMMUNIC, INC.10,360$12K
HUMAHumacyte Inc.16,199$10K
IFRXInflaRx N.V.10,800$10K
IGCIGC Pharma, Inc.33,848$9K
PMCBPharmaCyte Biotech, Inc.10,313$7K
BCABBioAtla, Inc.25,300$4K
IMMPImmutep Limited10,450$4K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.